Endogenous progesterone in unexplained infertility: a systematic review and meta-analysis
Open Access
- 27 December 2022
- journal article
- review article
- Published by Springer Nature in Journal of Assisted Reproduction and Genetics
- Vol. 40 (3) , 509-524
Abstract
Purpose: To investigate the possibility that altered actions of endogenous progesterone affect receptivity and contribute to unexplained infertility (UI).Methods: Two authors electronically searched MEDLINE, CINAHL and Embase databases from inception to 6 July 2022 and hand-searched according to Cochrane methodology. We included all published primary research reporting outcomes related to endogenous progesterone in natural cycles in women with UI. Studies were assessed for risk of bias using a modified Newcastle–Ottawa Score or NHLBI Score. We pooled results where appropriate using a random-effects model. Findings were reported as odds ratios or mean differences.Results: We included 41 studies (n = 4023). No difference was found between the mid-luteal serum progesterone levels of women with UI compared to fertile controls (MD 0.74, − 0.31–1.79,I236%). Women with UI had significantly higher rates of ‘out-of-phase’ endometrium than controls. Nine out of 10 progesterone-mediated markers of endometrial receptivity were significantly reduced in women with UI compared to fertile controls (the remaining 1 had conflicting results). Resistance in pelvic vessels was increased and perfusion of the endometrium and sub-endometrium reduced in UI compared to fertile controls in all included studies. Progesterone receptor expression and progesterone uptake were also reduced in women with unexplained infertility.Conclusions: End-organ measures of endogenous progesterone activity are reduced in women with UI compared to fertile controls. This apparently receptor-mediated reduction in response affects endometrial receptivity and is implicated as the cause of the infertility. Further research is required to confirm whether intervention could overcome this issue, offering a new option for treating unexplained infertility.Trial registration: PROSPERO registration: CRD42020141041 06/08/2020.Keywords
This publication has 99 references indexed in Scilit:
- Progesterone Is Essential for Protecting against LPS-Induced Pregnancy Loss. LIF as a Potential Mediator of the Anti-inflammatory Effect of ProgesteronePLOS ONE, 2013
- Predictive value of hormonal parameters for live birth in women with unexplained infertility and male infertilityReproductive Biology and Endocrinology, 2013
- Endometrial spiral artery Doppler parameters in unexplained infertility patients: is endometrial perfusion an important factor in the etiopathogenesis?Journal of the Turkish-German Gynecological Association, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Diminished Endometrial Expression of Ghrelin and Ghrelin Receptor Contributes to InfertilityReproductive Sciences, 2010
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- The cytokine receptor gp130 and its soluble form are under hormonal control in human endometrium and deciduaMolecular Human Reproduction, 2004
- The Immunological Pregnancy Protective Effect of Progesterone Is Manifested via Controlling Cytokine ProductionAmerican Journal of Reproductive Immunology, 1996
- Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?Immunology Today, 1993
- Clinical Importance of Endometrial Histology and Progesterone Level Assessment in Luteal-Phase DefectHormone Research, 1992